Study participants were recruited from the Copenhagen Macular Hole (COMAH) study, a randomized, controlled clinical trial comparing different methods of surgical treatment for macular hole. Inclusion criteria were having a unilateral idiopathic macular hole Gass stage 2 or 3, a normal fellow eye, preserved binocular function, best corrected visual acuity (BCVA) in the macular hole eye better than or equal to 0.1 (34 letters on the Early Treatment of Diabetic Retinopathy Study [EDTRS] chart), duration of symptoms less than 12 months, and ability to complete 6 months of follow-up. Exclusion criteria were current or past macular hole in the fellow eye, failed surgical closure of the macular hole in the study eye, epiretinal fibrosis, prior intraocular surgery other than cataract surgery, disease other than macular hole affecting or potentially affecting retinal function, a history of glaucoma or glaucoma being diagnosed at a screening visit, amblyopia, nystagmus, and strabismus, refractive error greater than ±5 D, and anisometropia greater than 3 D.
Baseline and 6-month follow-up examinations included a comprehensive ophthalmic examination including manual undilated refraction, assessment of BCVA at a 4-m distance, slit lamp biomicroscopy, mydriatic funduscopy, fundus photography, and optical coherence tomography (Stratus OCT3; Carl Zeiss Meditec, Dublin, CA). All patients who were phakic at inclusion underwent phacoemulsification with pseudophakic lens implantation 1 month before the baseline examination. The minimum inner diameter of the hole (
minimum diameter) and the hole diameter at the level of the retinal pigment epithelium (
maximum diameter) were measured with the built-in calipers of the system software.
10 In addition, patients completed a visual function questionnaire designed for the study. The questionnaire was presented to the patient and answered before the baseline examination.
All patients underwent surgical treatment for macular hole and were studied before and after treatment. The standardized surgical procedure included pars plana vitrectomy, removal of the posterior hyaloid, fluid–gas exchange using C
3F
8 gas, and randomized assignment to plain vitrectomy or vitrectomy with internal limiting membrane (ILM) peeling, the latter subgroup again being randomized to vital dye staining with indocyanine green or trypan blue. Comparison of outcome for the different surgical subgroups is published in a separate article.
11 Patients were asked to maintain face-down positioning during 10 hours per day for 5 days after surgery.
The study enrolled 55 patients with a unilateral stage 2 (
n = 19) or stage 3 (
n = 36) macular hole. Preoperative interocular disparity findings in these 55 patients have been published.
9 Thirteen patients were excluded for various reasons: three did not achieve macular hole closure, one developed a macular hole in the fellow eye, six were unavailable for planned follow-up because of late enrollment, one withdrew from the study, and two did not undergo differential perimetry testing because of instrument failure. With the exclusion of the 13 patients, the present analysis includes 42 eyes in 42 patients.
All participants gave written informed consent before inclusion. The study was approved by the medical ethics committee of Copenhagen County (KA04144) and registered with the National Institutes of Health as a clinical trial. The study was conducted according to the Declaration of Helsinki.